FDA to Limit Future ”COVID-19” Vaccines to High-Risk Groups
FDA to Limit Future ”COVID-19” Vaccines to High-Risk Groups The FDA announces a policy shift to restrict future ”COVID-19” vaccine approvals to individuals aged 65 and older and those with high-risk medical conditions, aligning with international standards:. The U,S. Food and Drug Administration ”(FDA)” has announced a Significant policy Shift,, limiting future COVID – 19 … Read more